# Clinical Practice of Hydromorphone in Multimodal Analgesia for Enhanced Recovery After Surgery (ERAS) in Knee Arthroplasty

> **NCT07722234** · NA · COMPLETED · sponsor: **China-Japan Friendship Hospital** · enrollment: 90 (actual)

## Conditions studied

- VAS Score
- Quadriceps Strength

## Interventions

- **DRUG:** Hydromorphone
- **DRUG:** Ropivacaine

## Key facts

- **NCT ID:** NCT07722234
- **Lead sponsor:** China-Japan Friendship Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2026-03-10
- **Primary completion:** 2026-06-10
- **Final completion:** 2026-06-13
- **Target enrollment:** 90 (ACTUAL)
- **Last updated:** 2026-07-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07722234

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07722234, "Clinical Practice of Hydromorphone in Multimodal Analgesia for Enhanced Recovery After Surgery (ERAS) in Knee Arthroplasty". Retrieved via MORVS 2026-10-21 from https://api.morvs.ai/clinical/NCT07722234. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
